Analyser av Cinclus Pharma

Analysbevakning

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Cinclus Pharma: Linaprazan glurate receives approval in China - Redeye

Redeye leaves a comment following Cinclus’ announcement of linaprazan glurate having received market approval in China.

Redeye • 05 Dec 07:27

Cinclus Pharma Q3: Progress in preparations ahead of pivotal study - Redeye

Redeye provides a research update following the Q3 report published by Cinclus earlier today.

Redeye • 14 Nov 10:50

Cinclus Pharma: Agreed paediatric study plan - Redeye

Redeye leaves a comment following Cinclus’ recent announcement that it has agreed on Paediatric Investigation Plan (PIP) with EMA.

Redeye • 29 Oct 12:06

Cinclus Pharma: Successful completion of IMP manufacturing - Redeye

Redeye leaves a short comment following Cinclus’ recent announcement that the manufacturing of the Investigational Medicinal Product (IMP), ...

Redeye • 30 Sep 09:46

Cinclus Pharma: The gem hidden in plain sight - Redeye

Redeye initiates coverage of Cinclus Pharma, a Swedish biotech company offering a next-generation solution to the USD+5bn GERD treatment mar...

Redeye • 23 Sep 07:26